CLINICAL ROLE -
Progestin May Create Stem-Like Breast Cancer Cells
Discovery may lead to new immunotherapies for aggressive breast cancer.
Read More
Potential Breakthrough for Viral Diseases Discovered
Dicovery could lead to more effective treatments for influenza, rhinovirus, and HIV.
Trending News Today: FDA Seeks Nicotine Reduction in Cigarettes
Top news of the day from across the health care landscape.
Extended-Release Abilify Approved for Bipolar Disorder
Aripiprazole (Abilify Maintena) found to delay manic episodes in adults with bipolar 1 disorder.
Transgender Women Voice Concerns About Potential Harmful HIV Drug Interaction with Hormones
More than half of survey respondents with HIV reported concerns about possible drug-drug interactions.
Trending News Today: Bipartisan Healthcare Legislation Could Fix ACA Pitfalls
Top news of the day from across the healthcare landscape.
FDA Issues Safety Alert for Compounded Triamcinolone and Moxifloxacin Drug
The FDA has issued a safety alert after receiving serious adverse events reports regarding intravitreal (eye) injections of a medication containing triamcinolone and moxifloxacin.
Diabetic Retinopathy Associated With Significant Visual-Function Issues
Severe diabetic retinopathy has a more detrimental effect on visual function than lesser forms of the disease.
Top 5 HIV Drugs in the Pipeline
Long-acting HIV medications could solve problems with adherence, reduce costly laboratory tests to monitor their efficacy, and bring down drug costs.
FDA Requests Manufacturer to Stop Distribution of Unapproved Dermatologic Products
Crown Laboratories Inc manufactures both prescription and OTC medications, including prescription urea cream and lotion.
Potenial Changes to Medicare Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Concurrent Chemotherapy, High-Dose Proton Beam Radiotherapy Show Promise in Advanced Lung Cancer
Technique offers improved survival in patients with advanced, inoperable stage 3 non-small cell lung cancer.
NCPA Innovation Center Announces Mental Health First Aid Instructor Training Scholarship Winners
Pharmacy Week in Review: July 28, 2017
A look at the top stories in pharmacy last week.
Watch
FDA to Enlist Help from Insurers, PBMs in Fight Against Opioid Epidemic
FDA plans multifaceted attack to reduce the burden of opioids on Americans.
Medicaid Enrollees Largely Satisfied with Coverage
Medicaid insurance not observed to create a barrier to receiving healthcare.
Precision Medicine Revives Leukemia Drug
Gemtuzumab ozogamicin observed to benefit subset of patients with acute myeloid leukemia.
World Hepatitis Day Tops SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Several Barriers Promote Non-Adherence to Statins Among Stroke Survivors
One-third of strokes worldwide occur in stroke survivors.
Underlying Mechanisms of HIV-Associated Neurocognitive Disorders
HIV patients lack crucial peroxisomal proteins in the brain.
Trending News Today: 'Skinny' Repeal Bill Fails in Senate
Immune System May Attack Brain in Parkinson's Disease
Findings identify a potential biomarker that may improve diagnosis and treatment of Parkinson’s disease.
Brain Cancer Preceded by Immune Changes Detected in Blood
Dampened cytokine interaction may indicate asymptomatic glioma.
WHO Prequalifies Generic Hepatitis C Drug, HIV Self-Test
Prequalification will allow countries to access generic sofosbuvir and an HIV self-test.
Aggressive Prostate Cancer Possibly Influenced by Height, Weight
Every 10 cm increase in waist size found to increase risk of high-grade prostate cancer by 13%.
Trending News Today: Skinny Repeal Bill Fails in the Senate
World Hepatitis Day: New WHO Data Reveal Why We Should Care, How Far We Have Come
Approximately 325 million individuals are living with hepatitis worldwide.
The Voices of Hepatitis C: Patients Discuss Their Fight Against HCV for World Hepatitis Day
Those who battled hepatitis C recount their journey to spread awareness on World Hepatitis Day.
Dermatology Drug Manufacturer to Cease Distribution of Unapproved Products
Tennessee drug company Crown Laboratories Inc. has agreed to cease the manufacturing and distribution of unapproved and misbranded dermatologic creams and lotions.
